NCT01538576View on ClinicalTrials.gov

Paediatric Subjects - Special Survey

CompletedOBSERVATIONAL

Enrollment

71

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Interventions

DRUG

insulin aspart

Prescribed by the physicians as a result of normal clinical practice

Trial Locations (1)

1000005

Tokyo

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY

NCT01538576 - Paediatric Subjects - Special Survey | Biotech Hunter | Biotech Hunter